Adamis Pharmaceuticals Corporation ADMP
0.78 +0.78
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 4.76M | 2.21M | 2.78M | 22.11M | 15.09M | |
| 4.76M | 2.21M | 2.78M | 22.11M | 15.09M | |
| 6.19M | 6.87M | 6.33M | 15.48M | 9.80M | |
| -1.43M | -4.66M | -3.55M | 6.64M | 5.29M | |
| 23.63M | 27.41M | 32.79M | 35.99M | 44.75M | |
| 10.38M | 11.26M | 8.04M | 10.38M | 18.79M | |
| 13.25M | 16.14M | 20.09M | 25.29M | 25.95M | |
| -25.06M | -32.07M | -36.34M | -29.35M | -39.46M | |
| -44.13K | 6.65K | 4.92K | 123.26K | 157.76K | |
| 2.00K | 796 | 2.40K | 8.67K | -369.34K | |
| -26.48M | -45.83M | -49.39M | -27.51M | -39.01M | |
| -26.48M | -45.83M | -49.39M | -27.51M | -39.01M | |
| -26.48M | -45.83M | -49.39M | -27.51M | -39.01M | |
| -26.48M | -45.83M | -49.39M | -27.51M | -39.01M | |
| 278.87K | 11.23M | 13.54M | 0 | 0 | |
| -12.60 | -22.40 | -44.80 | -36.40 | -70.00 | |
| -12.60 | -22.40 | -44.80 | -36.40 | -70.00 | |
| -12.60 | -22.40 | -44.80 | -36.40 | -70.00 | |
| -26.52M | -45.82M | -49.38M | -27.38M | -39.22M | |
| -26.52M | -45.82M | -49.38M | -27.38M | -39.22M | |
| 2.14M | 2.06M | 1.11M | 760.91K | 558.36K | |
| 2.14M | 2.06M | 1.11M | 760.91K | 558.36K |